National Comprehensive Cancer Network



About NCCN

Prevention and Treatment of Cancer-Related Infections Panel - Disclosures as of 4/28/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Michael Angarone, DO

None

None

None

None

None

10/9/2014

Lindsey Robert Baden, MD

NIH funded research

None

None

None

None

10/8/2014

William Bensinger, MD

Bristol-Myers Squibb Company;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Pharmacyclics;
sanofi-aventis U.S.

Bristol-Myers Squibb Company;
Celgene Corporation;
Novartis Pharmaceuticals Corporation;
sanofi-aventis U.S.

None

None

None

4/7/2015

Gayle Blouin, PharmD, BCOP

None

None

None

None

None

9/17/2014

Bernard C. Camins, MD

Theravance;
Pfizer Inc.

None

None

None

None

10/13/2014

Corey Casper, MD, MPH

None

None

None

None

None

10/14/2014

Erik R. Dubberke, MD

Merck & Co., Inc.;
Optimer/Cubist;
Rebiotix;
sanofi-aventis U.S.

Merck & Co., Inc.;
Rebiotix;
sanofi-aventis U.S.

None

None

None

1/29/2014

Alison G. Freifeld, MD

astellas

None

Galderma

None

None

1/27/2014

John N. Greene, MD

None

None

None

None

None

10/8/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

4/15/2015

Karin Hoffmann, RN

None

None

None

None

None

2/26/2015

James I. Ito, MD

City of Hope

Astellas;
Vical

Merck & Co., Inc.;
Astellas

None

None

11/17/2014

Daniel R. Kaul, MD

Chimerix;
NeuralStem;
ViroPharma

None

None

Chimerix;
ViroPharma

None

10/16/2014

Earl King, MD

None

None

None

None

None

12/3/2009

Mark E. Lustberg, MD, PhD

None

None

None

None

None

10/16/2014

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Jose G. Montoya, MD

K-PAX;
K-PAX Pharmaceuticals

Cubist Pharmaceuticals

None

None

None

12/11/2014

Ashley Morris Engemann, PharmD, BCOP

None

Astellas

None

None

None

10/8/2014

Ken Rolston, MD

Durata;
Forest;
Theravance

Theravance

None

None

None

10/16/2014

Gowri Satyanarayana, MD

None

None

None

None

None

4/14/2015

Brahm Segal, MD

Merck & Co., Inc.;
Astellas;
Cleveland Biolabs;
Ventrus

Merck & Co., Inc.;
Astellas

None

None

None

10/13/2014

Susan K. Seo, MD

None

None

None

None

None

11/17/2014

Shmuel Shoham, MD

Merck & Co., Inc.;
Ansun;
Astellas;
Chimerix;
Viropharma;
Pfizer Inc.

Theravance

None

None

None

3/16/2015

Courtney Smith, PhD

None

None

None

Johnson & Johnson;
OPKO

Ethos Health Communications

11/7/2014

Sankar Swaminathan, MD

GLG

None

None

Bristol-Myers Squibb Company;
Merck & Co., Inc.;
Pfizer Inc.

None

3/19/2015

Randy Taplitz, MD

None

None

None

None

None

8/14/2014

Jeffrey Topal, MD

None

None

None

None

None

10/14/2014

John W. Wilson, MD

None

None

None

None

None

10/12/2014